|1.||Scozzafava, Andrea: 3 articles (01/2008 - 03/2003)|
|2.||Supuran, Claudiu T: 3 articles (01/2008 - 03/2003)|
|3.||Swenson, Erik R: 2 articles (04/2007 - 01/2007)|
|4.||Vullo, Daniela: 2 articles (05/2003 - 03/2003)|
|5.||Pastorekova, Silvia: 2 articles (05/2003 - 03/2003)|
|6.||Pastorek, Jaromir: 2 articles (05/2003 - 03/2003)|
|7.||Colvin, Christopher J: 1 article (08/2015)|
|8.||Abramovitch, Robert B: 1 article (08/2015)|
|9.||Johnson, Benjamin K: 1 article (08/2015)|
|10.||Champion, Patricia A DiGiuseppe: 1 article (08/2015)|
|1.||Open-Angle Glaucoma (Glaucoma, Open Angle)
|2.||Duodenal Ulcer (Curling's Ulcer)
02/01/1986 - "Duodenal ulcer healing was followed by endoscopy in 186 ethoxzolamide-treated patients. "
02/01/1986 - "Treatment of duodenal ulcers with ethoxzolamide, an inhibitor of gastric mucosa carbonic anhydrase."
02/01/1986 - "Ethoxzolamide is superior to antacids and anticholinergics in healing duodenal ulcers."
09/01/1978 - "Ethoxzolamide, which was already 1958 clinically evaluated (Gordon-Posner), represents a valuable medication for conservative glaucoma therapy."
09/01/1978 - "Ethoxzolamide is a potent carboxyanhydrase inhibitor, and its use in chronic glaucoma and in the acute glaucoma attack is described in the present investigation. "
09/01/1978 - "[Clinical tests on the use of ethoxzolamide in glaucoma therapy (author's transl)]."
09/07/2012 - "Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy."
11/06/2013 - "This work focuses on the suitability of poly-(cyclo)dextrins as carriers able to solubilize the carbonic anhydrase inhibitor (CAI) ethoxzolamide (ETOX), which is so far used for oral treatment of glaucoma. "
04/01/2007 - "Using fluorescent microscopy, we tested the effect of AZ as well as two other potent CA inhibitors, benzolamide and ethoxzolamide, which exhibit low and high membrane permeability, respectively, on hypoxia-induced responses in PASMCs. "
01/01/2007 - "With benzolamide and ethoxzolamide, mean pulmonary artery pressure increased by 6-7 mmHg and pulmonary vascular resistance by 150-200 dyn.s.cm(-5) during hypoxia (P < 0.05). "
10/01/1972 - "Chloride and bicarbonate ions accompany the net flux of sodium across this tissue.3. Some experiments suggest that potassium is actively transported from the ventricular to the serosal surface, and that the rate of transport is a function of the extracellular potassium concentration.4. No evidence was obtained to suggest that calcium is actively transported across this tissue in either direction.5. Diamox, ethoxyzolamide, pitocin, pitressin, hydrocortisone, amiloride, spironolactone and anoxia all failed to influence sodium transport.6. The sequence of passive ion permeation across the plexus was P(Rb) approximately P(K) > P(Cs) approximately P(Na) approximately P(Cl) approximately P(HCO3) > P(Li) as deduced from diffusion potential measurements. "
05/22/2003 - "All these compounds, together with the six clinically used sulfonamide inhibitors (acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, and brinzolamide) were investigated as inhibitors of the transmembrane, tumor-associated isozyme carbonic anhydrase (CA) IX. Inhibition data against the classical, physiologically relevant isozymes I, II, and IV were also obtained. "
03/24/2003 - "The inhibition of the tumor-associated transmembrane carbonic anhydrase IX (CA IX) isozyme has been investigated with a series of aromatic and heterocyclic sulfonamides, including the six clinically used derivatives acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide and brinzolamide. "
|1.||Cholinergic Antagonists (Anticholinergics)
|3.||Carbonic Anhydrases (Carbonic Anhydrase)